Фуразолидон

Quick links

Choose a section

Quick links to important sections

Advertisements

Фуразолидон

Selected form

Advertisements
Advertisements

Method of action: Antiprotozoal

Treatment option: Diarrhea, Dysentery, Enteritis

Advertisements

Overview of Фуразолидон

What is Фуразолидон (Furazolidone)?

Property Description
Active ingredient Furazolidone (INN)
Form Tablets, Oral Suspension
Pharmacological class Nitrofuran Antimicrobial Agent
Common use Fighting bacterial and protozoal infections
Origin Synthetic

1. Identity and Chemical Class of the Medicine

Фуразолидон (Furazolidone) is a synthetic pharmaceutical compound that serves as a single-active ingredient product. Its chemical framework places it within the Nitrofuran derivative class, where the active substance is Furazolidone.

This core chemical identity establishes its function as a broad-spectrum antimicrobial agent, addressing both bacterial and certain protozoal pathogens. This dual capacity means the drug is clinically recognized for confronting infections caused by a wide variety of microorganisms, making it a valuable option in specific therapeutic contexts.

2. General Purpose and Action Against Germs

The general purpose of Furazolidone is to support the body in resolving infectious and inflammatory diseases by actively killing the causative agents. Furazolidone is microbicidal in its action, which means it is designed to actively kill the target microorganisms rather than merely slow their replication.

This potent effect is achieved by the drug interfering with multiple microbial enzyme systems and by binding to the organism's DNA. This highly effective action minimizes the ability of susceptible germs to survive and spread, supporting the clearance of the pathogenic load.

3. Composition and Available Forms

Furazolidone is formulated for oral administration and is typically presented in two common dosage form(s): tablets and as an oral suspension (a liquid form). Both preparations contain the same active ingredient Furazolidone along with inactive excipients necessary for stability and administration.

Although the drug was once marketed under the brand name Furoxone, it is now most widely available as the generic INN compound. The availability of the oral suspension form is a key feature, as it ensures the medication can be accurately administered to patients, including children, who may have difficulty swallowing solid medication.

Advertisements

What side effects are possible with Фуразолидон?

Possible side effects and safety information

The safety profile of Furazolidone is officially documented by regulatory authorities, classifying possible adverse reactions by frequency and physiological system. The most common types of effects relate to the Gastrointestinal System, while specific constraints are associated with the drug's properties as a Monoamine Oxidase Inhibitor (MAOI).

Classification Examples of Adverse Reactions (Regulatory-listed)
Less Common Nausea, vomiting, abdominal or stomach pain, headache
Rare Fever, skin rash, joint pain, itching

The drug's effects extend to other System-Organ Classes, including the Nervous System (headache, risk of peripheral neuropathy) and the Blood and Lymphatic System (risk of hemolytic anemia). In some cases, the medication may cause urine to change color, appearing dark yellow to brown.

Serious Adverse Reactions and Safety Constraints

Regulatory documents highlight several serious adverse reactions and safety constraints:

  • Peripheral Neuropathy: This risk is associated with long-term exposure or doses larger than officially recommended.
  • Hemolytic Anemia: This is a documented risk, specifically restricting use in infants up to 1 month of age and requiring caution in patients with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.
  • Hypertensive Crisis: Due to the drug's MAOI activity, a severe increase in blood pressure is possible if tyramine-containing foods or specific pressor amine medications are co-administered. This dietary restriction must be maintained for a period after treatment ends.
  • Disulfiram-like Reaction: The co-ingestion of alcohol is officially restricted during therapy and for up to four days after cessation due to the risk of this severe reaction.

These safety classifications and constraints formally define the conditions under which the medication's risk profile is managed, based on official regulatory standards.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The following information details the officially documented overdose manifestations and mandated emergency actions for Furazolidone, based on authoritative government regulatory documents.


Documented Overdose Manifestations

Classification Signs and Outcomes Documented in Labeling
Systemic Presentations Orthostatic hypotension, Hypoglycemia, and an acute fall in blood pressure are documented systemic presentations of over-exposure.
Severe Outcomes The potential for hypertensive crisis and seizures are listed as severe, life-threatening complications that require immediate professional intervention.

Official Emergency Actions Required

In all cases of suspected overdose, regulatory guidance requires individuals to seek immediate medical attention. Specifically, patients must contact a poison control center immediately or proceed to the nearest emergency room for urgent care.

No specific antidote is known for Furazolidone overdose. Therefore, the official management approach is defined as symptomatic and supportive treatment. Hospitalization and continuous observation are required to monitor and stabilize vital functions. Special consideration is given to children and elderly patients due to increased toxicity risk, and to patients with G6PD deficiency due to the risk of severe hemolytic effects.

Advertisements

Therapeutic Uses of Фуразолидон

Quick Facts: Uses of Furazolidone

  • Giardiasis: May be utilized as an option to address infections caused by the Giardia lamblia parasite.
  • Bacterial Diarrhea and Enteritis: Employed in the management of diarrhea and inflammation of the intestines caused by susceptible bacterial organisms.
  • Cholera: Used as a therapeutic option in the treatment of cholera, which is caused by Vibrio cholerae.

What Furazolidone Treats: Main Uses and Benefits

Furazolidone is a medicinal agent that is recognized for its utility in managing specific gastrointestinal infections. Its established therapeutic domains focus on conditions caused by certain bacteria and protozoa.

This medication is a consideration for the management of giardiasis, an infection resulting from the Giardia lamblia parasite. It is also employed as an option in the treatment of cholera. Furthermore, Furazolidone may be used to address diarrhea and enteritis that are caused by susceptible bacterial organisms within the intestinal tract.

The therapeutic goal is to assist in the resolution of the underlying infection. It is important to note that Furazolidone may be administered alongside other medicinal agents, depending on the clinical context.

This agent is considered a secondary option for some bacterial diarrheal illnesses and giardiasis. Consult a licensed healthcare professional for all specific questions regarding whether this option is appropriate for your condition.

Advertisements

Eligibility and Restrictions for Use

The use of Furazolidone is strictly governed by official population eligibility rules outlined in regulatory labeling. The medicine is contraindicated in specific populations and requires caution in others.


Absolute Contraindications

Furazolidone must not be used if there is a known hypersensitivity to the drug or any other nitrofuran compound. It is also contraindicated for all infants under 1 month of age, which is an exclusion based on the documented potential risk of hemolytic anemia due to immature enzyme systems.


Conditional Use and Restrictions

Use requires caution or supervision in patients with certain conditions or risk factors, as documented by regulatory agencies:

  • Metabolic: Individuals with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.
  • Organ Function: Patients with impaired liver function or impaired kidney function.
  • Substance Use: The drug should not be used if the patient cannot strictly avoid alcohol consumption during therapy and for at least four days afterward.
  • Concomitant Use: Caution is required when used alongside Monoamine Oxidase (MAO) inhibitors.

Age and Physiological Status

Furazolidone is approved for adults and children who are 1 month of age and older. Safety during pregnancy has not been established, and it is not recommended for nursing mothers of infants under 1 month. Official data to compare the safety and efficacy in the older adult population is insufficient.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Фуразолидон ( Furazolidone) is officially documented as a Monoamine Oxidase Inhibitor (MAOI), which mandates strict regulatory constraints regarding co-administered substances, foods, and beverages. The primary risk outcomes include Hypertensive Crisis and Serotonin Syndrome.


Formally Contraindicated Combinations

The following products and substances are formally prohibited for use during Furazolidone therapy, based on their documented interaction profiles:

  • Alcohol (Ethanol): Contraindicated due to the risk of a severe disulfiram-like reaction.
  • Tyramine-Containing Foods: Contraindicated due to the risk of Hypertensive Crisis; includes aged cheeses, yeast/meat extracts, and certain fermented products.
  • Sympathomimetic Amines: Contraindicated due to the risk of Hypertensive Crisis; includes cold/sinus medicines and decongestants containing agents like pseudoephedrine or phenylephrine.
  • Serotonergic Agents: Contraindicated due to the risk of Serotonin Syndrome; includes other MAOIs, SSRIs, and products containing substances like dextromethorphan.

Pharmacodynamic and Timing Constraints

  • Potentiation Effects: Co-administration with CNS depressants (e.g., sedatives) or antihypertensive agents may lead to additive effects, such as enhanced CNS depression or increased hypotensive activity, as noted in labeling.
  • Mandatory Avoidance Window: All contraindicated medicines and tyramine-containing foods must be avoided for at least 14 days following the discontinuation of Furazolidone therapy. Alcohol must be avoided for at least four days after the last dose. This mandatory period is required for the drug's enzyme-inhibiting effects to subside.
Advertisements

Mechanism of Action

Microbial Activation and Genetic Catastrophe

The drug operates as a prodrug, requiring activation by nitroreductase enzymes found exclusively within susceptible bacteria and protozoa. This enzymatic reduction transforms Фуразолидон into highly reactive metabolites. These intermediates immediately attack and cross-link the microbial DNA, which simultaneously prevents gene transcription and cell replication. This irreparable genetic damage, combined with non-selective binding to essential microbial enzymes, is the core of the microbicidal mechanism, resulting in microbial cell death.

Multi-Target Metabolic Shutdown

Beyond genetic interference, the reactive metabolites also induce a widespread metabolic crisis by covalently inhibiting numerous key microbial enzyme systems, particularly those involved in energy production and respiration. This dual attack—blocking replication and crippling energy supply—supports a potent microbicidal action. This multi-target mechanism relies on a non-selective chemical attack on basic microbial processes and reduces the pathogen's capacity for cellular repair.

Systemic Modulation of Host Amine Metabolism

A crucial pharmacodynamic consequence involves the drug’s major metabolite, AOZ ( 3-amino-2-oxazolidone), which acts as an irreversible Monoamine Oxidase Inhibitor (MAOI) in the host. This mechanism interferes with the body's natural breakdown of circulating amines, which is a systemic effect separate from the primary antimicrobial action. This secondary modulation results in the interference with the host's normal catabolism of monoamines.

Advertisements

Dosage and Administration Information

The administration of Furazolidone is standardized through established protocols for oral use. The medicine is available as a 100 mg tablet and as an oral suspension for liquid dosing. The standard regimen for adults involves taking 100 mg per dose, with the total daily amount typically set at 400 mg. This amount is generally administered in a four times daily pattern, corresponding to doses taken at approximately 6 hour intervals.

The overall duration of use is defined as lasting between 5 and 10 days depending on the specific infection being addressed, and the entire prescribed course must be completed. For administration flexibility, the drug may be taken with food. Specific preparation is required for the liquid form: the oral suspension must be shaken vigorously before each dose is measured using a designated device. Furthermore, tablets may be crushed and given with a vehicle for easier pediatric administration.

Standard guidelines provide specific information for different populations. Pediatric dosing for children over 1 month of age is calculated based on body weight, typically 5 mg per kg of body weight over 24 hours, divided into four doses. Documentation states that the drug must not be given to infants younger than one month. Adherence to the schedule is procedural: a missed dose should be taken as soon as possible, but under no circumstances should doses be doubled.

Advertisements

Recent Clinical Evidence

Furazolidone: Recent Clinical Evidence

Furazolidone is an antimicrobial nitrofuran derivative primarily used to treat bacterial and protozoal infections of the gastrointestinal tract, such as diarrhea, enteritis, and cholera. Its mechanism of action involves inhibiting several bacterial enzyme systems, which is thought to lead to a bactericidal effect.


Efficacy in Gastrointestinal Infections

Clinical research has focused on the agent's effectiveness against common causes of infectious diarrhea, particularly Giardia lamblia and certain strains of Escherichia coli. Controlled studies have evaluated its utility as a treatment option:

  • Giardiasis: Trials comparing furazolidone to other antiparasitic agents have been conducted. Findings suggest that while furazolidone is effective in treating symptomatic giardiasis, alternative therapies may be preferred due to potential side effect profiles or better tolerability in some populations.
  • Bacterial Enteritis: Studies have examined furazolidone's role in managing diarrhea caused by susceptible bacteria. These investigations have generally assessed clinical symptom resolution and eradication rates in patients.

Safety and Tolerability Profile

Data from clinical trials indicate that common adverse effects associated with furazolidone include gastrointestinal disturbances (e.g., nausea, vomiting) and headache. A known consideration is the risk of a disulfiram-like reaction when consumed with alcohol, which is a key patient safety factor investigated in studies.

Research has also explored potential interactions with tyramine-containing foods, due to the compound’s activity as a monoamine oxidase inhibitor (MAOI), although this effect is typically not of major clinical concern at standard therapeutic doses.

Key Studies & References

  1. Furazolidone (Oral Route) Drug Information, Professional - E-lactancia
  2. Furazolidone - Mechanism, Indication, Contraindications, Dosing, Adverse Effect, Interaction, Hepatic Dose - Pediatric Oncall
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Фуразолидон (FAQ)

Q: Чем Фуразолидон отличается от обычных антибиотиков?

Official information describes this medicine as belonging to the Nitrofuran class of antimicrobial agents, which is chemically distinct from typical antibiotics like penicillin. Its mechanism is microbicidal—designed to kill microorganisms—by causing irreparable damage to microbial DNA and interfering with multiple enzyme systems, indicating a multi-target action.

Q: Может ли Фуразолидон изменить цвет мочи?

Yes, official regulatory information confirms that the medication may cause a change in urine color. This change is typically described as the urine taking on a dark yellow to brown hue.

Q: Что делать, если пропустил прием дозы Фуразолидона?

The official administration protocol describes a recommendation to take the missed dose as soon as possible, if that is consistent with the regimen. It is explicitly noted in the protocol that the dose should not be doubled to make up for the missed one.

Q: Влияет ли Фуразолидон на печень?

Regulatory warnings indicate that caution is required when this medicine is used in patients who already have impaired liver function. The requirement for caution indicates that liver function is a factor considered during its administration.

Q: Можно ли принимать Фуразолидон, если есть хронические проблемы с почками?

Regulatory documents describe that use requires caution or medical supervision in patients with existing impaired kidney function. This constraint is listed as a consideration regarding eligibility.

Q: Как долго Фуразолидон остается в организме после окончания приема?

Although the active drug may be eliminated quickly, its secondary enzyme-inhibiting effects persist. Official regulatory constraints state that certain foods and medicines must still be avoided for at least 14 days following the discontinuation of the medicine, and alcohol for a minimum of four days.

Q: Правда ли, что на фоне приема Фуразолидона нельзя есть сыр?

The official restriction is specifically on tyramine-containing foods, which include aged cheeses (such as cheddar, brie, or parmesan). These foods are formally prohibited due to the risk of a severe increase in blood pressure.

Q: Можно ли принимать Фуразолидон без назначения врача?

The drug's official regulatory classification requires a prescription. Therefore, according to drug labeling, it is typically classified as a prescription-only medicine (Rx).

Q: Помогает ли Фуразолидон при отравлении?

The medicine’s documented purpose is to treat bacterial and protozoal infections of the gastrointestinal tract, such as diarrhea, enteritis, and cholera. It is not labeled or documented for the treatment of non-infectious poisoning.

Q: Используют ли Фуразолидон при расстройстве желудка или диарее?

The drug is officially indicated for the treatment of infectious conditions of the gastrointestinal tract, including diarrhea caused by susceptible bacteria and protozoa. Its use is focused on treating these specific infectious causes.

Q: Влияет ли Фуразолидон на управление автомобилем?

Regulatory safety information lists potential effects on the Nervous System as possible adverse reactions. These include symptoms like headache and the risk of peripheral neuropathy, which may affect attention or coordination.

Q: Нужна ли специальная диета при приеме Фуразолидона?

Official warnings document a special constraint that involves strictly avoiding alcohol and all tyramine-containing foods during therapy. These constraints are required due to the risk of severe adverse reactions.

Q: Взаимодействует ли Фуразолидон с другими лекарствами от простуды?

Regulatory documents officially contraindicate co-administration with certain common cold and sinus medicines. Specifically, those containing sympathomimetic amines (like pseudoephedrine) or serotonergic agents (like dextromethorphan) must be avoided.

Q: Почему Фуразолидон иногда назначают при лямблиозе?

Research evidence indicates that the medicine is considered effective in treating symptomatic giardiasis (Giardia lamblia). Its use is sometimes advocated, particularly in pediatric populations, because it is available in an oral suspension form suitable for children.

Q: Применяют ли Фуразолидон для профилактики кишечных инфекций?

The documented purpose of the drug is the treatment of established bacterial and protozoal infections of the gastrointestinal tract. It is not indicated for the prevention (prophylaxis) of intestinal infections.

Q: Может ли Фуразолидон вызвать аллергическую реакцию?

Regulatory documents list hypersensitivity to the drug as an absolute contraindication for its use. Furthermore, skin rash and itching are listed among the possible rare adverse reactions.

Q: Правда ли, что Фуразолидон влияет на нервную систему?

Yes, the official regulatory safety profile documents effects extending to the Nervous System. Listed adverse reactions include common occurrences like headache and the risk of the more serious reaction known as peripheral neuropathy.

Q: Какие неинфекционные заболевания лечат Фуразолидоном?

Official indications define the drug's purpose as fighting bacterial and protozoal infections of the gastrointestinal tract. It is not documented for the treatment of non-infectious diseases.

Q: Почему некоторые врачи считают, что Фуразолидон менее эффективен, чем новые средства?

Regulatory literature and research themes suggest that while the medicine is effective, alternative therapies are sometimes preferred. This preference is often due to reported differences in potential side effect profiles or generally better tolerability in some populations.

Advertisements

How should Фуразолидон be stored and disposed of?

Storage and Disposal of Furazolidone

Storage of Furazolidone must strictly comply with official regulatory labeling to ensure product stability and safety.

Required Storage Conditions

Condition Requirement
Temperature Store at a temperature not exceeding 25, C (or 30, C depending on region).
Protection Keep the medicine in a dry place and protected from light.
Packaging Must be kept in the original container and not used past the expiration date.
Safety The product must be stored out of the sight and reach of children.

Disposal

The disposal of unused or expired Furazolidone should follow regulatory protocols. The recommended method is utilizing a drug take-back program. If a take-back program is unavailable, the medicine must be prepared for household trash by mixing it with an unappealing substance (like dirt or used coffee grounds) and sealing the mixture in a container before discarding. Furazolidone must not be flushed down the toilet or poured down the sink.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Фуразолидон found in:

A-Z Index: